B-Cell CLL/Lymphoma 2 (BCL2) and Cytochrome C Oxidase II (COX2), both downstream NF-κB effectors, are upregulated and associated with apoptotic resistance in BE [103, 104]. Here, BCL2 is linked to Barrett esophagus.